{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:04:40Z","timestamp":1791216280477,"version":"4.1.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Giant, cystic renal tumors are generally considered relatively contraindicated for laparoscopic surgery. We report on a 19-year-old male, where polycystic lesions in the left kidney were accidentally noted by enhanced computed tomography (CT) by focusing on the diagnostic, clinical, and surgery to the patient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Report<\/jats:title><jats:p>Enhanced CT scan revealed solid component in multiple cystic lesions of Bosniak IV, which was enhanced after injection of contrast agent and the left kidney lost normal profile and enlarged with maximal diameter more than 18cm. Positron emission tomography-computed tomography (PET-CT) showed SUVmax 4.8 of the lesion and suggested malignant disease. A retroperitoneal laparoscopic radical left nephrectomy was performed successfully without cyst burst and the lesion was 17\u00d717\u00d718 cm in size. Pathological examination revealed that the lesions were consistent with papillary renal cell carcinoma (type 2, WHO grade II), no renal capsule invasion, no renal pelvis and renal sinus fat involvement, no abnormality in ureter and renal arteriovenous end, no abnormality in a few adrenal tissues, chronic inflammation of hilar lymph nodes (0\/1). After surgery, no specific treatment was initiated and at a follow-up visit 1 year after surgery, no local recurrence or metastasis was found.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>It is the largest cystic renal cell carcinoma that has ever been reported for laparoscopic resection. The selection of surgery for giant cystic renal cell carcinoma should be individualized. Retroperitoneal laparoscopy may be an option for such lesions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.876217","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T13:41:36Z","timestamp":1652362896000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Giant Polycystic Papillary Renal Cell Carcinoma: A Case Report and Literature Review"],"prefix":"10.3389","volume":"12","author":[{"given":"Zhongming","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.currproblcancer.2021.100773","article-title":"Kidney Cancer: From Genes to Therapy","volume":"45","author":"Webster","year":"2021","journal-title":"Curr Probl Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"102228","DOI":"10.1016\/j.ctrv.2021.102228","article-title":"Checkpoint Inhibitors in Metastatic Papillary Renal Cell Carcinoma","volume":"99","author":"de Vries-Brilland","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1773-y","article-title":"Renal Cell Carcinoma Recurrences and Metastases in Primary Non-Metastatic Patients: A Population-Based Study","volume":"34","author":"Dabestani","year":"2016","journal-title":"World J Urol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of Renal Cell Carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1148\/rg.293085190","article-title":"Papillary Renal Cell Carcinoma: Radiologic-Pathologic Correlation and Spectrum of Disease","volume":"29","author":"Vikram","year":"2009","journal-title":"Radiographics"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1189-1","article-title":"Imaging Features of Papillary Renal Cell Carcinoma With Cystic Change-Dominant Appearance in the Era of the 2016 WHO Classification","volume":"42","author":"Honda","year":"2017","journal-title":"Abdominal Radiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.17.18421","article-title":"Solid Small Renal Mass Without Gross Fat: CT Criteria for Achieving Excellent Positive Predictive Value for Renal Cell Carcinoma","volume":"210","author":"Park","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.urology.2007.05.029","article-title":"Surgical Resection Provides Excellent Outcomes for Patients With Cystic Clear Cell Renal Cell Carcinoma","volume":"70","author":"Webster","year":"2007","journal-title":"Urology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-39842014000200015","article-title":"Bosniak Classification of Renal Cystic Lesions According to Multidetector Computed Tomography Findings","volume":"47","author":"de Miranda","year":"2014","journal-title":"Radiol Bras"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13112617","article-title":"Clear Cell Renal Cell Carcinoma: Discrimination From Other Renal Cell Carcinoma Subtypes and Oncocytoma at Multiphasic Multidetector CT","volume":"267","author":"Young","year":"2013","journal-title":"Radiology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.12460","article-title":"Qualitative and Quantitative MDCT Features for Differentiating Clear Cell Renal Cell Carcinoma From Other Solid Renal Cortical Masses","volume":"203","author":"Lee-Felker","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.3372","article-title":"Assessment of Cell Proliferation in Renal Cell Carcinoma Using Dual-Phase 18F-Fluorodeoxyglucose PET\/Ct","volume":"10","author":"Onishi","year":"2015","journal-title":"Oncol Lett"},{"key":"B13","article-title":"18f-FDG-PET\/CT in Potentially Advanced Renal Cell Carcinoma: A Role in Treatment Decisions and Prognosis Estimation","volume":"33","author":"Ferda","year":"2013","journal-title":"Anticancer Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/1471-2407-10-667","article-title":"Impact of Maximum Standardized Uptake Value (SUVmax) Evaluated by 18-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography\/Computed Tomography (18F-FDG-PET\/CT) on Survival for Patients With Advanced Renal Cell Carcinoma: A Preliminary Report","volume":"10","author":"Namura","year":"2010","journal-title":"BMC Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12885-016-2097-4","article-title":"FDG PET\/CT as a Prognostic Biomarker in the Era of Molecular-Targeting Therapies: Max SUVmax Predicts Survival of Patients With Advanced Renal Cell Carcinoma","volume":"16","author":"Nakaigawa","year":"2016","journal-title":"BMC Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000220","article-title":"Papillary Renal Cell Carcinoma (PRCC): An Update","volume":"26","author":"Akhtar","year":"2019","journal-title":"Adv Anat Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.04.013","article-title":"Papillary Renal Cell Carcinoma: Review","volume":"39","author":"Mendhiratta","year":"2021","journal-title":"Urol Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2015.05.008","article-title":"Papillary Renal Cell Carcinoma: A Review of the Current Therapeutic Landscape","volume":"96","author":"Courthod","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70162-7","article-title":"Safety and Efficacy of Sunitinib for Metastatic Renal-Cell Carcinoma: An Expanded-Access Trial","volume":"10","author":"Gore","year":"2009","journal-title":"Lancet Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066838","article-title":"Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma","volume":"356","author":"Hudes","year":"2007","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2019.1548939","article-title":"The Molecular Characterization and Therapeutic Strategies of Papillary Renal Cell Carcinoma","volume":"19","author":"Chen","year":"2019","journal-title":"Expert Rev Anticancer Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2019182646","article-title":"Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment","volume":"292","author":"Silverman","year":"2019","journal-title":"Radiology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.22146","article-title":"Cytomorphologic Comparison of Type 1 and Type 2 Papillary Renal Cell Carcinoma: A Retrospective Analysis of 28 Cases","volume":"127","author":"Magers","year":"2019","journal-title":"Cancer Cytopathol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12894-020-00716-0","article-title":"Comparison of Clinicopathologic Parameters and Oncologic Outcomes Between Type 1 and Type 2 Papillary Renal Cell Carcinoma","volume":"20","author":"Le","year":"2020","journal-title":"BMC Urol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-019-0211-5","article-title":"The Cancer Genome Atlas of Renal Cell Carcinoma: Findings and Clinical Implications","volume":"16","author":"Linehan","year":"2019","journal-title":"Nat Rev Urol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2020.09.020","article-title":"Routine or Enhanced Imaging to Differentiate Between Type 1 and Type 2 Papillary Renal Cell Carcinoma","volume":"76","author":"Li","year":"2021","journal-title":"Clin Radiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"21073","DOI":"10.1038\/s41598-020-78174-9","article-title":"The Effect of the Papillary Renal Cell Carcinoma Subtype on Oncological Outcomes","volume":"10","author":"Pan","year":"2020","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.123","article-title":"Treatment Outcome and Survival Associated With Metastatic Renal Cell Carcinoma of Non-Clear-Cell Histology","volume":"20","author":"Motzer","year":"2002","journal-title":"J Clin"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70586-2","article-title":"Docetaxel Plus Nintedanib Versus Docetaxel Plus Placebo in Patients With Previously Treated Non-Small-Cell Lung Cancer (LUME-Lung 1): A Phase 3, Double-Blind, Randomised Controlled Trial","volume":"15","author":"Reck","year":"2014","journal-title":"Lancet Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-017-2430-6","article-title":"Histologic Subtype Needs to Be Considered After Partial Nephrectomy in Patients With Pathologic T1a Renal Cell Carcinoma: Papillary vs. Clear Cell Renal Cell Carcinoma","volume":"143","author":"Yoo","year":"2017","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.876217\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T13:41:38Z","timestamp":1652362898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.876217\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":30,"alternative-id":["10.3389\/fonc.2022.876217"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.876217","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"article-number":"876217"}}